Introduction of surveillance of infections with Staphylococcus aureus containing the Panton-Valentine Leukocidin gene in the Netherlands
Author(s) -
Edine Tiemersma,
W J B Wannet,
Eline Op de Coul,
Albert J. de Neeling,
M J W van de Laar
Publication year - 2003
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.07.16.02206-en
Subject(s) - panton–valentine leukocidin , leukocidin , staphylococcus aureus , outbreak , microbiology and biotechnology , virology , toxin , medicine , biology , methicillin resistant staphylococcus aureus , bacteria , genetics
The National Institute of Public Health and the Environment (RIVM) in the Netherlands has begun surveillance of Staphylococcus aureus (MRSA) strains with the Panton-Valentine Leukocidin (PVL) gene in the Netherlands. This PVL gene is known to produce a potent toxin causing severe skin infections and necrotising pneumonia in both immunocompromised and immunocompetent individuals. About 60% of PVL positive isolates in the Netherlands belonged to ‘cluster 28’, which is an epidemic strain in the European mainland, but which has not yet caused large outbreaks in the Netherlands.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom